Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

NK cells play a role in skin diseases like eczema and psoriasis.

Inflammation damages sweat ducts, causing sweat gland injury.

Hedgehog signaling can create new hair follicles but may also cause tumors.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Composite biomaterials can precisely control immune responses for better disease treatment.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

SM04755 may be an effective topical treatment for psoriasis.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Shh and Dhh affect skin development and can cause tumors, while Ihh does not.